Putting the “rule of five” of drug research in context
Lipinski’s “rule of five”, 1 very well known by medicinal chemists, has been defined as a set of rules, based on the number 5 -hence its name-, to evaluate the “drug-likeness” of a given molecule. The rules are: – The molecule should have no more than 5 H-bond donors and 10 H-bond acceptors (i.e. N […]